Latest news with #Kewalramani
Time of India
5 days ago
- Business
- Time of India
Meet Reshma Kewalramani who joins the list of 100 Most Powerful People in Business 2025 alongside Jensen Huang, Sundar Pichai, and others
Reshma Kewalramani, born in Mumbai and now CEO of Vertex Pharmaceuticals, has earned a coveted spot on Fortune's 2025 list of the 100 Most Powerful People in Business. Ranked at number 62, she is the only Indian-origin woman CEO of a major US biotechnology company to make this year's list. Tired of too many ads? go ad free now While global names like Mark Zuckerberg, Sundar Pichai, Satya Nadella, and Mukesh Ambani also appear on the list, Kewalramani's recognition marks a monumental achievement for women in science-led industries. Her rise from a physician in Boston hospitals to the helm of a $110 billion biotech company is a remarkable journey of leadership, innovation, and impact in the global healthcare landscape. Who is Reshma Kewalramani: The Mumbai-born biotech CEO on Fortune's 2025 Most Powerful Business Leaders list Born in Mumbai, Reshma Kewalramani moved to the United States when she was just 11 years old. With a passion for medicine, she pursued her education and began her career as a physician at Massachusetts General Hospital and Brigham and Women's Hospital—two of the most prestigious medical institutions in the US. Her early experiences in clinical settings laid a strong foundation for her future in biotechnology, where patient-centered care and scientific innovation go hand in hand. In 2020, Reshma Kewalramani made history by becoming the first woman to lead a major US biotechnology company. She joined Vertex Pharmaceuticals in 2017 and quickly ascended the ranks—becoming Chief Medical Officer in 2018 and then CEO just two years later. Her appointment was more than a personal milestone—it symbolized a breakthrough in gender representation in a field traditionally dominated by men, especially at the executive level. Vertex Pharmaceuticals grows to $110 billion under Reshma Kewalramani Under her leadership, Vertex Pharmaceuticals has grown into a biotech powerhouse valued at $110 billion. Tired of too many ads? go ad free now The company is known for its innovations in treating cystic fibrosis and continues to expand its pipeline with bold research in rare diseases. Most notably in 2025, the company received FDA approval for Journavx, a revolutionary non-opioid pain treatment. This approval is being hailed as a landmark in the global fight against the opioid epidemic—a crisis that has devastated millions. Kewalramani's unique edge as a licensed physician gives her a dual perspective—scientific and strategic. Unlike many biotech CEOs who come from a purely business background, she brings hands-on clinical experience to boardroom decisions. This medical insight has been crucial in shaping Vertex's patient-first approach to drug development and innovation, further elevating its global credibility and impact. Reshma Kewalramani ranks 62 on Fortune's influential business leaders list Now in its second edition, Fortune's 100 Most Powerful People in Business celebrates individuals who wield influence, drive innovation, and shape the future of industry—not merely those with the highest net worth. Kewalramani's entry at rank 62 is a clear indication of her growing stature in the international business and biotech communities. The top ranks this year feature: Jensen Huang (CEO of Nvidia) – Rank 1 Satya Nadella (CEO of Microsoft) – Rank 2 Sundar Pichai (CEO of Google) – Rank 6 Mukesh Ambani (Chairman of Reliance Industries) – Rank 56 Neal Mohan (CEO of YouTube) – Rank 83 Gautam Adani (Industrialist) – Rank 96 While Reshma Kewalramani may not yet be a household name, her work is transforming lives. Her quiet but impactful leadership style focuses on meaningful science, global health, and diverse representation in leadership. This is her first time on the Fortune list, and it signifies global acknowledgment of her contributions not just to business, but to humanity through science. Also Read |
News18
7 days ago
- Business
- News18
Who Is Reshma Kewalramani? Mumbai-Born Trailblazer Joins Fortune's 100 Most Powerful List
Last Updated: Kewalramani, CEO of Vertex Pharmaceuticals, joins Fortune's 100 Most Powerful People in Business. Ranked 62nd, she is the 1st woman CEO of a major US biotech firm on the list. As Fortune magazine released its list of 100 Most Powerful People in Business, a Mumbai-born woman has also secured a spot among the global leaders. A Mumbai-born physician and CEO of Vertex Pharmaceuticals, Reshma Kewalramani has joined global business leaders like Mukesh Ambani, Sundar Pichai, and Mark Zuckerberg on the list. Ranked 62nd, Kewalramani is recognised for breaking barriers by becoming the first woman CEO of a major US biotechnology company. She has led Vertex Pharmaceuticals, currently valued at $110 billion, since April 2020 and also sits on its board of directors. All About Reshma Kewalramani Born in Mumbai, Kewalramani moved to the United States with her family, at the age of 11. She began her career as a physician at Massachusetts General Hospital and Brigham and Women's Hospital. Transitioning to the biopharma industry, she held multiple leadership roles in research and development before joining Vertex in 2017. A year later, she was promoted to Chief Medical Officer, and by 2020, she became CEO. Fortune highlighted her leadership in securing FDA approval for Journavx, a new opioid-free pain medication, highlighting the impact of her medical background on the company's innovative direction. Now in its second edition, Fortune's list focuses on individuals with significant influence and decision-making power in actively run businesses shaping the future. The ranking prioritizes leadership and strategic impact over net worth or public visibility. Other Indian and Indian-origin executives on the 2025 list include Microsoft CEO Satya Nadella at rank 2, Google CEO Sundar Pichai at rank 6, Reliance Industries Chairman Mukesh Ambani at rank 56, YouTube CEO Neal Mohan at rank 83, and Adani Group Chairman Gautam Adani at rank 96. Kewalramani's inclusion marks her debut on the list and underscores her growing influence in both biotech and global business leadership. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
NDTV
7 days ago
- Business
- NDTV
Mumbai-Born CEO Joins Fortune 100 List With Satya Nadella, Sundar Pichai
Indian-origin CEO Reshma Kewalramani has made it to the world's 100 Most Powerful People in Business. Ranked 62 by Fortune magazine, the President of Vertex Pharmaceuticals joins an elite list that includes tech giants Mark Zuckerberg and Sundar Pichai. This is her first appearance on Fortune's prestigious list, which features leaders actively shaping the present and future of global business. "This list measures power and influence, and though net worth is a factor, we're much more concerned with a leader's ability to shape the thoughts and actions of those around them," the magazine says. Other Indian and Indian-origin leaders on Fortune's list include Microsoft CEO Satya Nadella (rank 2), Google CEO Sundar Pichai (rank 6), Mukesh Ambani (rank 56), YouTube CEO Neal Mohan (rank 83), and Gautam Adani (rank 96). Nvidia's Jensen Huang tops the list. Who Is Reshma Kewalramani? Ms Kewalramani stands out as the first woman to lead a major US biotechnology company. She was appointed CEO of Vertex Pharmaceuticals in April 2020, after joining the firm in 2017 and serving as its Chief Medical Officer. A physician by training, she brings deep clinical expertise to her leadership role. Born in Mumbai, she moved to the US at the age of 11. She earned her medical degree from Boston University and trained at Massachusetts General Hospital and Brigham and Women's Hospital. She later completed Harvard Business School's General Management Programme. Under Ms Kewalramani's stewardship, Vertex, currently valued at over $110 billion, has seen a string of medical breakthroughs. Most recently, the company won FDA approval for Journavx, a first-of-its-kind opioid-free pain treatment in over two decades. Vertex is also known for its pioneering therapies for cystic fibrosis and, more recently, for advancing gene-editing treatments for sickle cell disease and beta thalassemia. In profiling her, Fortune writes: "Reshma Kewalramani, who brings her experience as a licensed doctor to her leadership, took the helm as CEO of Vertex Pharmaceuticals in 2020, having previously served as the biopharma company's chief medical officer." Reshma Kewalaramani Net Worth Ms Kewalramani's net worth is estimated at over $100 million as of mid-2025. This includes ownership of Vertex shares worth around $47.5 million and approximately $53.6 million earned through stock sales since 2021. Her 2024 CEO compensation package, combining salary, bonuses, and stock, was valued at $21.5 million. She also serves on the board of Ginkgo Bioworks and was named to TIME magazine's 2025 list of the "100 Most Influential People."
Time of India
7 days ago
- Business
- Time of India
She moved to the US at 11. India-origin CEO in Fortune's list with Ambani and Adani. Check education and career of Reshma Kewalramani
Who is Reshma Kewalramani? Reshma Kewalramani's education background and career Fortune 100 Most Powerful People in Business From Bombay to the boardrooms of one of the world's leading biotech firms, Reshma Kewalramani 's journey is nothing short of extraordinary. The Indian-origin CEO, who moved to the US at the age of 11, now leads Vertex Pharmaceuticals—one of the world's top Fortune 500 companies. With a Harvard education, she's not only one of the most powerful women in global business but also among the wealthiest of Indian Kewalramani, MD, FASN, is the Chief Executive Officer and President of Vertex Pharmaceuticals , a global biotech powerhouse known for developing life-changing medicines. She joined the company in 2017 and quickly rose through the ranks, serving as Chief Medical Officer and EVP of Global Medicines Development before being appointed CEO in 2020. Under her leadership, Vertex has secured approval for five breakthrough drugs that treat the underlying cause of cystic fibrosis (CF), transforming the lives of thousands of journey began in medicine. Kewalramani earned her medical degree with honours from the seven-year program at Boston University Chobanian & Avedisian School of Medicine. She completed her internship and residency in internal medicine at Massachusetts General Hospital, followed by a fellowship in nephrology at the joint program between Mass General and Brigham and Women's Hospital. Later, she expanded her expertise into leadership, completing the General Management Program at Harvard Business School.A Fellow of the American Society of Nephrology, Kewalramani has been widely recognised for her impact in healthcare and leadership. She has been named to both the TIME 100 Most Influential People in the World and TIME 100 Health lists, cementing her reputation as a visionary in the biotech industry Nvidia CEO and cofounder Jensen Huang has landed the No. 1 spot on Fortune's 2025 list of the world's 100 most powerful businesspeople. The other tech heavyweights in the top 10—Microsoft's Satya Nadella, Meta's Mark Zuckerberg, Alphabet's Sundar Pichai, and Huawei's Ren Zhengfei—are all chasing after more of Huang's in-demand chips. But even at the top, there's no time to relax. With powerful rivals closing in, Huang knows the pressure is always on.
Economic Times
7 days ago
- Business
- Economic Times
She moved to the US at 11. India-origin CEO in Fortune's list with Ambani and Adani. Check education and career of Reshma Kewalramani
Synopsis Reshma Kewalramani, an Indian-origin CEO, leads Vertex Pharmaceuticals, a Fortune 500 biotech firm, after moving to the US at 11. A Harvard graduate, she rose through the ranks to CEO in 2020, securing approval for five breakthrough cystic fibrosis drugs. Recognized by TIME, Kewalramani exemplifies science, leadership, and perseverance in modern medicine. Reshma Kewalramani is the CEO and President at Vertex Pharmaceuticals. (LinkedIn) From Bombay to the boardrooms of one of the world's leading biotech firms, Reshma Kewalramani's journey is nothing short of extraordinary. The Indian-origin CEO, who moved to the US at the age of 11, now leads Vertex Pharmaceuticals—one of the world's top Fortune 500 companies. With a Harvard education, she's not only one of the most powerful women in global business but also among the wealthiest of Indian Kewalramani, MD, FASN, is the Chief Executive Officer and President of Vertex Pharmaceuticals, a global biotech powerhouse known for developing life-changing medicines. She joined the company in 2017 and quickly rose through the ranks, serving as Chief Medical Officer and EVP of Global Medicines Development before being appointed CEO in 2020. Under her leadership, Vertex has secured approval for five breakthrough drugs that treat the underlying cause of cystic fibrosis (CF), transforming the lives of thousands of patients. Her journey began in medicine. Kewalramani earned her medical degree with honours from the seven-year program at Boston University Chobanian & Avedisian School of Medicine. She completed her internship and residency in internal medicine at Massachusetts General Hospital, followed by a fellowship in nephrology at the joint program between Mass General and Brigham and Women's Hospital. Later, she expanded her expertise into leadership, completing the General Management Program at Harvard Business School. A Fellow of the American Society of Nephrology, Kewalramani has been widely recognised for her impact in healthcare and leadership. She has been named to both the TIME 100 Most Influential People in the World and TIME 100 Health lists, cementing her reputation as a visionary in the biotech industry. Nvidia CEO and cofounder Jensen Huang has landed the No. 1 spot on Fortune's 2025 list of the world's 100 most powerful businesspeople. The other tech heavyweights in the top 10—Microsoft's Satya Nadella, Meta's Mark Zuckerberg, Alphabet's Sundar Pichai, and Huawei's Ren Zhengfei—are all chasing after more of Huang's in-demand chips. But even at the top, there's no time to relax. With powerful rivals closing in, Huang knows the pressure is always on.
